STAT | Reporting from the frontiers of health and medicine

Skip to Main Content

Experience STAT's journalism live at an upcoming STAT Summit

Experience STAT's journalism live at an upcoming STAT Summit

August 27, 2025

STAT Plus: Harvard funding cuts threaten program that aims to help children with rare, undiagnosed diseases
August 26, 2025

STAT Plus: Akeso says its closely watched drug improved patient survival in a lung cancer trial
August 26, 2025

STAT Plus: New report details the state of the biotech industry in Mass. The results are grim
August 26, 2025

STAT Plus: Health AI investment: Traits of success and the reckoning
August 26, 2025

STAT Plus: Eli Lilly’s obesity pill helped lower weight, blood sugar in key Phase 3 trial
August 26, 2025

Hospice was meant to offer dignity in death — but it fails the most marginalized

Explore the power, profits, and pressures behind UnitedHealth Group

Download the report

STAT Plus: The most burdensome diseases globally are the least studied, but the gap is narrowing

Diseases that cause the most harm are often the least-researched. While that is changing, research cuts threaten that progress, study says

Exclusive August 27, 2025

Top Democratic senator launches inquiry into for-profit methadone clinics

Politics August 26, 2025

Trump’s hand bruise renews attention to his health — and his heart

First Opinion August 27, 2025

Engage the community in generative AI for public health

Biotech August 27, 2025

Third Rock tops STAT’s VC rankings, boosted by early biotech investments

Sponsored

Advertisement

Sign up for Newsletters

STAT+

Your go-to source for the world of life sciences, medicine, and biopharma. Subscribe now.

Cancel anytime.

STAT Plus: FDA pulls biologics license for chikungunya vaccine

STAT Plus: Amid cries for retraction, a medical journal reviews a discredited, 24-year-old paper on an antidepressant

STAT Plus: New report details the state of the biotech industry in Mass. The results are grim

STAT Plus: AbbVie to buy Gilgamesh’s psychedelic drug for up to $1.2 billion

As MAHA turns 1, a fired-up movement is still figuring out how to fulfill its promises

All STAT+ Stories

All Events

More From STAT

More From STAT

More From STAT

STAT offers a variety of in-person and virtual events throughout the year.

All Events

Strategic Approaches to Operational Excellence & Regulatory Compliance

Virtual

Join speakers from Ecolab and Avid Bioservices who will share industry-leading insights and practices.

Bridging Gaps in Asthma Care

Virtual

Local Ecosystem, Global Market: Building Biotech Hubs that Thrive in Dynamic Conditions

Cambridge, MA

An Evening With TPM & STAT News

Cambridge, MA

All Events

All Trackers

More From STAT

More From STAT

More From STAT

We create tools to help you understand and track complex areas of development.

All Trackers

Obesity Drug Tracker

Here are the dozens of weight loss drugs in development to catch a booming market.

CRISPR Tracker

Follow the latest developments in genome editing.

Generative AI Tracker

A guide to the health systems and companies driving adoption.

Breakthrough Device Tracker

An authoritative database of FDA’s fast-tracked medical devices.

All Reports

More From STAT

More From STAT

More From STAT

STAT Reports blend data insights with qualitative observations on pivotal life sciences topics.

All Reports

Inside UnitedHealth’s empire

$39

Discover how UnitedHealth Group quietly grew from a traditional health insurer into one of the most powerful — and controversial — players in American health care.

All Podcasts

More From STAT

More From STAT

More From STAT

From policy to practice: STAT's podcasts decode health care complexities.

All Podcasts

The Readout LOUD

Our weekly biotech podcast digs deep into industry goings-on.

First Opinion Podcast

Our opinion podcast discusses the people, issues, and ideas that are shaping health care.

Color Code

Our podcast raising the alarm on racial inequities in American health care.

More From STAT

Events Trackers Reports Podcasts

More Stories

Health August 27, 2025

STAT Plus: Harvard funding cuts threaten program that aims to help children with rare, undiagnosed diseases

Biotech August 26, 2025

STAT Plus: Akeso says its closely watched drug improved patient survival in a lung cancer trial

Biotech August 26, 2025

STAT Plus: New report details the state of the biotech industry in Mass. The results are grim

Health Tech Newsletter August 26, 2025

STAT Plus: Health AI investment: Traits of success and the reckoning

Pharma August 26, 2025

STAT Plus: Eli Lilly’s obesity pill helped lower weight, blood sugar in key Phase 3 trial

First Opinion August 26, 2025

Hospice was meant to offer dignity in death — but it fails the most marginalized

First Opinion August 26, 2025

We surveyed hundreds of biomedical researchers about the instability in federal funding. Here’s what they said

Biotech August 26, 2025

STAT Plus: Illumina CEO sees path to stable growth, even as its academic customers face funding uncertainty

Politics August 25, 2025

HHS terminates NIH program aimed at diversifying biomedical workforce

Health August 25, 2025

Maryland resident is diagnosed with New World screwworm. What to know about the parasite

Health August 25, 2025

Gene-edited pig lung transplanted into a brain-dead patient for first time

Biotech August 25, 2025

STAT Plus: AbbVie to buy Gilgamesh’s psychedelic drug for up to $1.2 billion

Pharmalot August 26, 2025

STAT Plus: Pharmalittle: We’re reading about an AbbVie deal for a psychedelic, Lilly obesity pill trial results, and more

Pharmalot August 25, 2025

STAT Plus: Pharmalittle: We’re reading about FDA reporting side effects, pharma plants near disaster zones, and more

The Readout August 25, 2025

STAT Plus: FDA pulls biologics license for chikungunya vaccine

Pharmalot August 25, 2025

STAT Plus: Amid cries for retraction, a medical journal reviews a discredited, 24-year-old paper on an antidepressant

Opinions+ August 25, 2025

STAT Plus: The future of medicine lies in multifunctional therapies

Politics August 23, 2025

STAT Plus: HHS moves to strip thousands of federal health workers of union rights

First Opinion August 27, 2025

Engage the community in generative AI for public health

First Opinion August 26, 2025

Hospice was meant to offer dignity in death — but it fails the most marginalized

First Opinion August 26, 2025

We surveyed hundreds of biomedical researchers about the instability in federal funding. Here’s what they said

First Opinion August 25, 2025

Testosterone made me feel 30 again — until it nearly broke my heart

Opinions+ August 25, 2025

STAT Plus: The future of medicine lies in multifunctional therapies

First Opinion August 22, 2025

Hospitals should not separate postpartum women in crisis from their newborns

Newsletters

Mon - Fri

Your daily dose of news in health and science

Our Picks

Our Picks

STAT’s selection of must-read stories and investigations

STAT Plus: As Sarepta Therapeutics fights for Duchenne therapy, a group of patients gets left behind

STAT Plus: Health care CEOs harvest billions even as industry lags broader stock market

By Bob Herman and J. Emory Parker

STAT Plus: Can a humble, Harley-riding professor and former Trump adviser fend off science cuts?

By Jonathan Wosen

STAT Plus: AI scribe companies promise to help doctors bill more. Who will pay the extra cost?

By Brittany Trang

STAT Plus: Why direct-to-consumer sales are unlikely to significantly lower drug costs

STAT Plus: In a new era, glucose sensors straddle the line between medical device and wellness tool

By Katie Palmer

STAT Plus: Did a drug prevent this man’s ALS?

STAT Plus: Jay Bhattacharya once studied health disparities. As NIH director, he’s allowed such research to wither

By Anil Oza, Usha Lee McFarling, and Eric Boodman

STAT Plus: FDA approves Ionis drug that prevents swelling attacks caused by a rare disease

Biotech August 21, 2025

STAT Plus: FDA approves Ionis drug that prevents swelling attacks caused by a rare disease

Biotech August 21, 2025

STAT Plus: Gilead’s Kite Pharma acquires Interius BioTherapeutics for $350 million

Biotech August 19, 2025

STAT Plus: Viking Therapeutics oral weight loss drug hits mark in mid-stage trial but disappoints investors

STAT Plus: Up and down the ladder: The latest comings and goings

Pharmalot August 22, 2025

STAT Plus: Up and down the ladder: The latest comings and goings

Pharmalot August 22, 2025

STAT Plus: Pharmalittle: We’re reading about a troubled Novo manufacturing plant, PEPFAR funding and more news

Pharmalot August 21, 2025

STAT Plus: Pharmalittle: We’re reading about Gilead’s HIV drug, FDA speeding review of a rare disease drug, and more

What updated thresholds for statin use could mean for patients

Health August 20, 2025

What updated thresholds for statin use could mean for patients

Health August 19, 2025

STAT Plus: National pediatrics group splits with RFK Jr. on Covid vaccinations

Health August 18, 2025

Texas declares its measles outbreak over

STAT Plus: FDA says it will publish reports of adverse events tied to drugs on daily basis

Politics August 22, 2025

STAT Plus: FDA says it will publish reports of adverse events tied to drugs on daily basis

Politics August 21, 2025

STAT Plus: Supreme Court lets Trump administration cut $783 million of research funding in anti-DEI push

Politics August 19, 2025

STAT Plus: Trump may push hard for lower drug prices using a tool created by Democrats

Video

STAT Plus: How AI scribes could usher in higher medical bills

STAT Plus: Deconstructing RFK Jr.’s explanation for the cancellation of mRNA vaccine contracts

Bill Gates goes all in on women’s health

STAT Plus: STAT breaks down the confusing, heartbreaking Sarepta saga

ALS

ALS

STAT Plus: He was 21 when he programmed MyChart. Now he’s the president of Epic

Health tech August 22, 2025

STAT Plus: He was 21 when he programmed MyChart. Now he’s the president of Epic

Health tech August 20, 2025

STAT Plus: Epic’s AI overhaul promises to address EHR headaches for clinicians and patients

Health tech August 14, 2025

STAT Plus: Can a computer turn our internal monologue into speech?

Brain map does not change following amputation, new study finds, upending assumptions

In the Lab August 21, 2025

Brain map does not change following amputation, new study finds, upending assumptions

In the Lab August 14, 2025

STAT Plus: Modified antibody shows promise for treating metastatic cancer, early trial shows

In the Lab August 8, 2025

STAT Plus: Trump administration launches investigation into Harvard’s federally funded research patents

STAT Plus: Hospitals nab $4 billion in extra Medicaid funds, before Republican cuts take effect

Hospitals July 25, 2025

STAT Plus: Hospitals nab $4 billion in extra Medicaid funds, before Republican cuts take effect

Hospitals June 16, 2025

STAT Plus: Senate GOP proposes steeper cuts to Medicaid funding in tax cut bill

Hospitals June 14, 2025

STAT Plus: Hospitals would be hit hardest by Medicaid cuts in GOP tax bill, report finds

STAT Plus: GLP-1s, cancer care are driving higher employer health care costs in 2026

Insurance August 20, 2025

STAT Plus: GLP-1s, cancer care are driving higher employer health care costs in 2026

Insurance July 18, 2025

STAT Plus: Judge dismisses Humana’s case over downgraded Medicare Advantage ratings

Insurance July 9, 2025

STAT Plus: Federal judge tosses Blue Cross Blue Shield of Louisiana lawsuit, another loss for Medicare Advantage insurers

Podcasts

Viking’s obesity flop, ‘pharma to table’ drug sales

Vinay Prasad’s return, animal testing alternatives, and mRNA upended

What Vinay Prasad’s ouster means for biotech and the FDA

Inside an FDA drug rejection, and layoffs at Sarepta